Such an exquisite sensitivity to CDK4/6 inhibition might be explained by the absence of oncogenic driver mutations affecting those signalling cascades in mesotheliomas, which are mostly characterized by the inactivation of tumour suppressor genes [8, 12, 13, 14]. The gene discussed is CDK4; the disease is mesothelioma.